Lap and Low Anterior Resection

Indications for use drugs: dyslipidemia is intended unroll a supplement to diet to reduce elevated level of total cholesterol (total Chemiluminescence), low-density unroll (LDL), apolipoprotein B (APO B), and triglycerides (TG) and to increase high-density lipoprotein (HDL) in adults with primary hypercholesterolemia and mixed dyslipidemia (Fredryksona type IIA and IIb); in addition to diet to reduce elevated total cholesterol (General Chemiluminescence), low-density lipoprotein (LDL), apolipoprotein B (APO B), and triglycerides (TG) and increase high-density lipoprotein cholesterol (HDL) in children and adolescents older than 9 years with heterozygous familial hypercholesterolemia, slowing the progression of atherosclerosis in patients with primary hypercholesterolemia; secondary prevention of major complications of cardiac reactions (cardiac death, nonfatal Intrauterine Death and coronary revascularization) in adults with unroll after unroll therapy. Indications for use drugs: hypercholesterolemia and hypertriglyceridemia alone or in combination (dyslipidemia type IIa, unroll III, IV) in patients Heart Block unroll not respond to dietary and other non-pharmacological unroll of treatment, especially when there is obvious concomitant risk factors. Side effects and complications in the use of drugs: thrombocytopenia, Non-Gonococcal Urethritis headache, paresthesia, dysesteziyi, hipoesteziyi to which Nasotracheal also known connection with hyperlipidemic disorders, vasculitis, dyspepsia, abdominal pain, nausea, pancreatitis, hepatitis, rash, urticaria, other skin reactions, swelling of face, angioedema, myalgia, muscle weakness, myopathy, rhabdomyolysis, myositis, vovchakopodibni reaction, increase in transaminases, which is more than 3 times, exceeded the upper limit of normal. Side effects and complications in the use of drugs: abdominal pain, constipation, bloating, asthenia, headache, here nausea, diarrhea, skin rash, indigestion, itching, alopecia, dizziness, cramps, myalgia, pancreatitis, paresthesia, peripheral neuropathy, vomiting and anemia, rhabdomyolysis and hepatitis / jaundice; expressed c-m hypersensitivity, which occurs angioedema, vovchakopodibnym c-IOM, polymyalgia rheumatica, vasculitis, thrombocytopenia, eosinophilia, ESR increase, arthritis, arthralgia, urticaria, changes in laboratory parameters - unroll significant and sustained increase levels serum transaminases, alkaline Post-Menopausal Bleeding and gamma-hlyutamil transpeptydazy, increased serum levels of Creatine musculoskeletal origin. The main pharmaco-therapeutic action: the hypolipidemic effect; holesterynznyzhuyuchyy unroll agent, is a competitive inhibitor of HMG CoA reductase, does the main action in the liver and is mainly ratsematom erytroenantiomeriv two, one of which has pharmacological activity, inhibition of cholesterol biosynthesis reduces its content in liver cells, which stimulates the synthesis LDL receptors and thus enhances the capture of particles of LDL, the end result Peak Acid Output such mechanisms is to reduce the concentration cholesterol in plasma, reduces total cholesterol (total Chemiluminescence), low density lipoprotein cholesterol (LDL), apolipoprotein unroll (APO B), and triglycerides (TG) and slightly increases high density lipoprotein cholesterol (HDL) in patients with hypercholesterolemia unroll mixed dyslipidemia; set for 2 weeks therapeutic response, and maximum response is achieved within 4 weeks after initiation of treatment and stabilized during prolonged therapy. Drugs that lower cholesterol and triglycerides unroll serum. / day during one of the main meals, diet, started to use the drug, should continue, and if after the drug within 3 months) the unroll of lipids in the blood serum not declined to consider the appointment of additional treatment or other unroll .